Company intelligence / Profile preview

PediaLean

Carrollton, Texas, United States

Ownership: Private
Development stage: Other

Overview

PediaLean was a healthcare company and brand that specialized in pediatric weight management products. Its primary offering was a dietary supplement containing glucomannan, a natural fiber intended to help children feel full and reduce overeating. The company operated as a subsidiary or brand under Wellness International Network and utilized a direct-sales business model. PediaLean is primarily remembered for a major 2003 FTC settlement regarding deceptive advertising and the lack of clinical evidence for its weight-loss claims in minors.

Therapeutic areas: Metabolic Disorders
Modalities: Dietary SupplementSmall molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on PediaLean.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PediaLean.

Explore the full profile